Assenagon Asset Management’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
Other funds holding APYX
ACM
DSCM
RI
RA
ACM
PVI
HKAM
CPA
TFCM
Assenagon Asset Management's APYX Position: Q2 2023 in Review
Assenagon Asset Management sold out of Apyx Medical (APYX) in Q2 2023, closing a stake of 93,720 shares — an estimated $270K sold.
Assenagon Asset Management first reported a position in APYX in Q2 2022 and held it in 4 quarters. The position peaked at $484K in Q2 2022. 56 funds tracked by Wall St. Rank hold APYX as of Q2 2023.
- Assenagon Asset Management reported no remaining Apyx Medical position as of Q2 2023 after selling out during the quarter.
- Assenagon Asset Management sold 93,720 Apyx Medical shares in Q2 2023, an estimated $270K.
- Assenagon Asset Management first reported a position in Apyx Medical in Q2 2022 and held it in 4 quarters.
- Assenagon Asset Management's Apyx Medical position peaked at $484K in Q2 2022.
- 56 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2023.
Based on Assenagon Asset Management's 13F filing for Q2 2023, filed 25 Jul 2023.